M6-C Artificial Cervical Disc

Prosthesis, Intervertebral Disc

FDA Premarket Approval P170036

Pre-market Approval Supplement Details

Approval for the m6-c artificial cervical disc. The m6-c artificial cervical disc is indicated for reconstruction of the disc following single level discectomy in skeletally mature patients with intractable degenerative cervical radiculopathy with or without spinal cord compression at one level from c3 to c7. Degenerative cervical radiculopathy is defined as arm pain and/or a neurological deficit (numbness, weakness, deep tendon reflexes changes) with or without neck pain due to disc herniation and/or osteophyte formation and confirmed by radiographic imaging (ct, mri, x-rays). The m6-c artificial cervical disc is implanted via an anterior approach. Patients should have failed at least 6 weeks of conservative treatment or exhibit progressive neurological symptoms which could lead to permanent impairment prior to implantation of the m6-c artificial cervical disc.

DeviceM6-C Artificial Cervical Disc
Classification NameProsthesis, Intervertebral Disc
Generic NameProsthesis, Intervertebral Disc
ApplicantSpinal Kinetics LLC
Date Received2017-10-31
Decision Date2019-02-06
Notice Date2019-02-11
PMAP170036
SupplementS
Product CodeMJO
Docket Number19M-0645
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address Spinal Kinetics LLC 501 Mercury Drive sunnyvale, CA 94085
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P170036Original Filing
S012 2022-10-17 30-day Notice
S011 2022-06-09 30-day Notice
S010 2022-03-08 30-day Notice
S009 2021-09-29 30-day Notice
S008 2020-12-22 Normal 180 Day Track No User Fee
S007 2020-09-17 30-day Notice
S006 2020-09-11 Normal 180 Day Track No User Fee
S005 2020-02-05 30-day Notice
S004 2020-01-09 30-day Notice
S003 2019-08-15 30-day Notice
S002 2019-04-17 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
00812388031305 P170036 000
00812388030209 P170036 000
00812388030216 P170036 000
00812388030223 P170036 000
00812388030230 P170036 000
00812388030247 P170036 000
00812388030254 P170036 000
00812388030261 P170036 000
00812388030278 P170036 000
00812388030285 P170036 000
00812388030292 P170036 000
00812388030193 P170036 000
00812388030186 P170036 000
00812388031312 P170036 000
00812388030094 P170036 000
00812388030100 P170036 000
00812388030117 P170036 000
00812388030124 P170036 000
00812388030131 P170036 000
00812388030148 P170036 000
00812388030155 P170036 000
00812388030162 P170036 000
00812388030179 P170036 000
00812388030308 P170036 000
00812388030315 P170036 000
00812388030322 P170036 000
00812388030452 P170036 000
00812388030469 P170036 000
00812388030476 P170036 000
00812388030018 P170036 000
00812388030025 P170036 000
00812388030032 P170036 000
00812388030049 P170036 000
00812388030056 P170036 000
00812388030063 P170036 000
00812388030070 P170036 000
00812388030445 P170036 000
00812388030438 P170036 000
00812388030339 P170036 000
00812388030346 P170036 000
00812388030353 P170036 000
00812388030360 P170036 000
00812388030377 P170036 000
00812388030384 P170036 000
00812388030391 P170036 000
00812388030407 P170036 000
00812388030414 P170036 000
00812388030421 P170036 000
00812388030087 P170036 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.